Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1977 1
2004 2
2006 1
2010 1
2011 1
2012 1
2013 2
2014 2
2016 1
2017 1
2018 1
2020 3
2021 3
2022 8
2023 6
2024 2
2025 11
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean barrier g[Author] (75 results)?
Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
Hervey-Jumper SL, Zhang Y, Phillips JJ, Morshed RA, Young JS, McCoy L, Lafontaine M, Luks T, Ammanuel S, Kakaizada S, Egladyous A, Gogos A, Villanueva-Meyer J, Shai A, Warrier G, Rice T, Crane J, Wrensch M, Wiencke JK, Daras M, Oberheim Bush NA, Taylor JW, Butowski N, Clarke J, Chang S, Chang E, Aghi M, Theodosopoulos P, McDermott M, Jakola AS, Kavouridis VK, Nawabi N, Solheim O, Smith T, Berger MS, Molinaro AM. Hervey-Jumper SL, et al. Among authors: warrier g. J Clin Oncol. 2023 Apr 10;41(11):2029-2042. doi: 10.1200/JCO.21.02929. Epub 2023 Jan 4. J Clin Oncol. 2023. PMID: 36599113 Free PMC article. Clinical Trial.
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, Phillips JJ, Braunstein SE, Raleigh DR, Theodosopoulos P, Aghi MK, Chang EF, Hervey-Jumper SL, Costello JF, de Groot J, Butowski NA, Clarke JL, Chang SM, Berger MS, Molinaro AM, Solomon DA. Hadad S, et al. Among authors: warrier g. Acta Neuropathol. 2023 Dec 11;147(1):3. doi: 10.1007/s00401-023-02654-1. Acta Neuropathol. 2023. PMID: 38079020 Free PMC article.
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Grover P, Lo SN, Li I, Kuijpers AMJ, Kreidieh F, Williamson A, Amaral T, Dimitriou F, Placzke J, Olino K, Vitale MG, Saiag P, Gutzmer R, Allayous C, Olofsson Bagge R, Mattsson J, Asher N, Carter TJ, Meniawy TM, Lawless AR, Czapla JA, Warburton L, Gaudy-Marqueste C, Grob JJ, Collins RG, Zhang E, Kessels JI, Neyns B, Mehmi I, Hamid O, Julve M, Furness AJS, Margolin KA, Lev-Ari S, Ressler JM, Haque W, Khattak MA, Wicky A, Roberts-Thomson R, Arance A, Warrier G, Schollenberger MD, Parente P, Chatziioannou E, Lipson EJ, Michielin O, Weber JS, Hoeller C, Larkin J, Atkins MB, Essner R, Johnson DB, Sullivan RJ, Nathan P, Schachter J, Lebbe C, Ascierto PA, Kluger H, Rutkowski P, Dummer R, Garbe C, Lorigan PC, Burton E, Tawbi HA, Haanen J, Carlino MS, Menzies AM, Long GV. Grover P, et al. Among authors: warrier g. Ann Oncol. 2025 Jul;36(7):807-818. doi: 10.1016/j.annonc.2025.03.021. Epub 2025 Apr 8. Ann Oncol. 2025. PMID: 40204154 Free article.
International real-world study of combination immunotherapy sequences in metastatic melanoma.
Guardamagna M, Lochrin SE, Smithy JW, Postow M, Gaudy-Marqueste C, Malissen N, Monestier S, Sullivan RJ, Czapla JA, Lawless AR, Pires da Silva I, Long GV, Menzies AM, Dimitriou F, Dummer R, Marchi C, Chaurand A, Dalle S, Ascierto PA, Paone M, Facchini BA, Warrier G, Lipson EJ, Erdmann M, Berking C, Archambaud B, Roy S, Routier E, Boutros C, Jamme P, Belkadi-Sadou D, Simon-Tillaux N, Robert C. Guardamagna M, et al. Among authors: warrier g. J Immunother Cancer. 2025 Nov 28;13(11):e012225. doi: 10.1136/jitc-2025-012225. J Immunother Cancer. 2025. PMID: 41314978 Free PMC article.
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
Joshi UM, Hundal J, Mata JR, Schollenberger MD, Warrier G, Luke JJ, Lipson EJ, Funchain P. Joshi UM, et al. Among authors: warrier g. Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e473856. doi: 10.1200/EDBK-25-473856. Epub 2025 Apr 15. Am Soc Clin Oncol Educ Book. 2025. PMID: 40233298 Free article. Review.
How Can Palliative Care Help Me?
Warrier G, Gupta A, Sedhom R. Warrier G, et al. JAMA Intern Med. 2023 Nov 1;183(11):1284. doi: 10.1001/jamainternmed.2023.4383. JAMA Intern Med. 2023. PMID: 37695619
Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning.
Mehari M, Warrier G, Dada A, Kabir A, Haskell-Mendoza AP, Tripathy A, Jha R, Nieblas-Bedolla E, Jackson JD, Gonzalez AT, Reason EH, Flusche AM, Reihl S, Dalton T, Negussie M, Gonzales CN, Ambati VS, Desjardins A, Daniel AGS, Krishna S, Chang S, Porter A, Fecci PE, Hollon T, Chukwueke UN, Badal K, Molinaro AM, Hervey-Jumper SL. Mehari M, et al. Among authors: warrier g. Sci Adv. 2025 Jun 6;11(23):eadt5708. doi: 10.1126/sciadv.adt5708. Epub 2025 Jun 4. Sci Adv. 2025. PMID: 40465719 Free PMC article.
Addressing Biased Patient Behavior: A Teachable Moment.
Sheffield V, Fraley L, Warrier G. Sheffield V, et al. Among authors: warrier g. JAMA Intern Med. 2021 Dec 1;181(12):1631-1632. doi: 10.1001/jamainternmed.2021.5719. JAMA Intern Med. 2021. PMID: 34605854 Review. No abstract available.
AstroID resource: a scalable, relational database structure for longitudinal biomarker discovery.
Will EM, Green BF, Carey S, Warrier G, Cottrell TR, Qadri A, Jorquera A, Soto-Diaz S, Wang D, Sunshine JC, Stein Deutsch J, Anders RA, Zhu QC, Danilova L, Cope L, Lipson EJ, Engle LL, Taube JM, Szalay AS. Will EM, et al. Among authors: warrier g. J Immunother Cancer. 2025 Dec 25;13(12):e012235. doi: 10.1136/jitc-2025-012235. J Immunother Cancer. 2025. PMID: 41448831 Free PMC article.
46 results